Stock & Company Details
ATAI Life Sciences N.V. $ATAI
Price:
N/A
N/A
N/A
$2.7B
52 Week High:
N/A
10 Day Average Volume:
N/A
-3.26
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Commercial Services
ATAI technical indicators
Latest ATAI Life Sciences N.V. (ATAI) indicator readings as of 2026-08-28.
ATAI's 14-day RSI is 63.3, in neutral territory. At $7.29 it is trading 58.9% above its 200-day moving average of $4.59, and above its 50-day average of $6.41. Price sits in the middle of its Bollinger Bands ($7.12 to $7.45). ADX reads 53.9, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
Finance Bot
Ask your questions
Start by typing a question below.
